Lunai Bioworks market cap LNAI
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Oct 29, 2026
- $830.7K
- Highest close in our data
- $35.6M
- Sep 2025
Lunai Bioworks is worth $830.7K at the close on Oct 29, 2026, at $0.17 a share.
That is down 96% over the last year.
Its highest close in our data was $35.6M in Sep 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $830.7K | $830.7K | $22.8M | −96% |
| 2025 | $22.8M | $20.2M | $35.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Lunai Bioworks' size, closest first, today.
| Company | Market cap |
|---|---|
| LNAILunai Bioworks | $830.7K |
| NXTSNexentis Technologies | $772.3K |
| DCOYDecoy Therapeutics | $678.1K |
| ARTLArtelo Biosciences | $1.1M |
| GOVXGeoVax Labs | $1.2M |
| MTNBMatinas BioPharma | $1.3M |
| SBFMSunshine Biopharma | $533.1K |
| VBIOValion Bio | $471.2K |
| LABTLakewood-Amedex Biotherapeutics | $438.4K |
| KAPAKairos Pharma, LTD. | $1.6M |
| OGENOragenics | $1.7M |
| Peer median | $940.1K |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Lunai Bioworks
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.